-
A cutting-edge technology and an exciting recent hire hint at exciting developments in the future of precision medicine in the diagnosis and treatment of Alzheimer's disease.
-
A medication that appears to preserve brain function after a stroke will soon go into human trials. The San Antonio researcher who discovered the medication's potential more than two decades ago is still leading the team.
-
Patients have been leaving the United States to try psychedelic therapies to treat their depression, PTSD, traumatic brain injuries, and substance use disorders. With so many patients finding relief, why do psychedelic therapies mostly remain illegal in the U.S., and how do psychedelics actually work?
-
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how to increase uptake. mRNA vaccine research may be on the chopping block, too.
-
Host Bonnie Petrie and reporter Robin Berghaus explore the potential of psychedelic medication as a treatment for mental health diagnoses like depression and PTSD, particularly for use in the veteran population.
-
Thousands of grant applications had been stalled when the Trump administration blocked the National Institutes of Health from posting notices to the Federal Register.
-
A San Antonio researcher is working on a drug that could treat Ewing sarcoma and rhabdomyosarcoma without lifelong side effects. It would be the first new treatment option for these childhood cancers in 30 years.
-
A new policy for how the National Institutes of Health will reimburse overhead costs associated with research grants could result in the loss of significant funding at institutions like UT Austin.
-
A new technique for delivering radiation to glioblastoma brain tumors may allow doctors to use much higher doses while preserving healthy brain tissue. UT Health San Antonio's Andrew Brenner, MD, PhD, says this may give patients more time.
-
UT Health San Antonio neuroscientist Yu Shin Kim, PhD, has discovered how stress causes migraines, which could lead to treatments that prevent them.